Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-23-009694

Chief Financial Officer sold 8,474 shares at $2.45 ($20,761)

  • Chief Financial Officer acquired 27,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Delfini Lisa · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-13 Exercise or conversion : show line 1 in the form +27,500 $0.51 $14,053 31,812 D
2023-02-13 Sale : show line 2 in the form −8,474 $2.45 $20,761 23,338 D
Open-market sales · 8,474 sh · avg $2.45 · $20,761

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-13 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −27,500 82,500 D
Loading xslF345X03/doc4.xml…